Exolumen
PrivateLast Round
Seed
May 1, 2024
Company Overview
Exolumen is a medical technology company that develops augmented reality-based surgical visualization projectors to assist surgeons with real-time anatomical data during reconstructive procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, AR/VR Hardware, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exolumen Comparables
Compare Exolumen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Illuminant Surgical | 85% | |
| SKIA | 78% | |
| Medivis | 76% |
Exolumen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2024
Completed a Seed funding round.
Exolumen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exolumen's valuation, stock price, and market status.
Is Exolumen a public or private company?
Exolumen is a private company.
What is the current stock price of Exolumen?
Exolumen is a private company, so its shares have no public market price. Caplight tracks Exolumen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exolumen worth (valuation)?
Valuation information for Exolumen is not publicly available.
Can I buy Exolumen stock?
Exolumen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exolumen's last funding round?
Exolumen's most recent funding round was Seed on May 1, 2024.
Who are the main investors in Exolumen?
Investor information for Exolumen is not publicly disclosed.
Will Exolumen IPO soon?
No public IPO plans have been announced for Exolumen.
How can I track Exolumen secondary market activity?
Caplight tracks bids, offers, and trades in Exolumen's shares on secondary markets.